1. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
- Author
-
Khudushina TA, Voloshina EP, Adamovich NV, Maslakova MG, and Terekhova ND
- Subjects
- Humans, Incidence, Moscow epidemiology, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis isolation & purification, Mycobacterium tuberculosis pathogenicity, Retrospective Studies, Sputum microbiology, Tuberculosis, Multidrug-Resistant diagnosis, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary epidemiology, Antibiotics, Antitubercular therapeutic use, Antitubercular Agents therapeutic use, Isoniazid therapeutic use, Rifampin therapeutic use, Tuberculosis, Multidrug-Resistant epidemiology, Tuberculosis, Pulmonary drug therapy
- Abstract
Statistics for the last 6 years show a trend to growing number of new cases with tuberculosis of the lungs with drug-resistant pathogen. In recurrent tuberculosis multiple drug resistance (MDR) was three times higher than in new cases. Treatment efficacy depended on MDR and patients' compliance. The results of the basic treatment course were unstable: many patients had exacerbation within 3-4 years after therapy, many patients died, especially those with M. tuberculosis resistant to many drugs.
- Published
- 2005